Hemorrhagic choroidal detachment after use of anti-glaucomatous eye drops: case report.
Eighty-two-year-old patient with a pacemaker using warfarin due to arrhythmia and having an intraocular lens in the right eye, developed spontaneous hemorrhagic choroidal detachment one day after the use of combined preparation of 0.5% timolol maleate and 0.004% travoprost, due to primary open-angle glaucoma. Hemorrhagic detachment was detected by anterior and posterior segment examination, as well as B-scan ultrasonography. After the detachment, excessive increased intraocular pressure was controlled with oral carbonic anhydrase inhibitor, cycloplegic and steroid therapy. After four months, visual acuity was 20/20 and the intraocular pressure was under control with 0.5% timolol maleate and 1% brinzolamide. Controlled reduction of the intraocular pressure should be considered, particularly in older patients under anticoagulant therapy and that had undergone prior ocular surgery.
Deniz Turgut
DT
Coban
Muhammet Kazim
MK
Erol
Ozgur
O
Yucel
D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002829:Choroid / Q000293:injuries*; D002832:Choroid Hemorrhage / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003008:Cloprostenol / Q000009:adverse effects / Q000031:analogs & derivatives*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009883:Ophthalmic Solutions; D013999:Timolol / Q000009:adverse effects*; D000069557:Travoprost; D014463:Ultrasonography
D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D003008:Cloprostenol; D013999:Timolol; D000069557:Travoprost